Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2007

01-11-2007 | Erratum

Erratum To: Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation

Authors: M. M. Schubert, F. P. Eduardo, K. A. Guthrie, J. C. Franquin, R. J. Bensadoun, C. A. Migliorati, M. Hamdi, W. Niccoli-Filho

Published in: Supportive Care in Cancer | Issue 11/2007

Login to get access

Excerpt

Support Care Cancer (2007) 15: 651-797 (DOI 10.1007/s00520-007-0262-7) …
Metadata
Title
Erratum To: Abstract of the 20th International Anniversary MASCC/ISOO Symposium: A Phase III randomized double-blind placebo controlled clinical trial to determine the efficacy of low level laser therapy for the prevention of oral mucositis in patients undergoing hematopoietic cell transplantation
Authors
M. M. Schubert
F. P. Eduardo
K. A. Guthrie
J. C. Franquin
R. J. Bensadoun
C. A. Migliorati
M. Hamdi
W. Niccoli-Filho
Publication date
01-11-2007
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-007-0324-x

Other articles of this Issue 11/2007

Supportive Care in Cancer 11/2007 Go to the issue

Original Article

Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer

Original Article

Usefulness of cutting needle biopsy in recurrent and advanced staged head and neck malignancies in a palliative setting

Original Article

Evaluation of the memorial delirium assessment scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals

Original Article

Developing supportive care for family members of people with lung cancer: a feasibility study

Supportive Care International

Change in quality of life in Chinese women with breast cancer: changes in psychological distress as a predictor

Original Article

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits